Freedom
LATEST NEWS
MedMen’s closure progresses as receiver oversees asset liquidation
MedMen’s properties in Illinois, Nevada, and New York are nearing sales, but the outlook in California and Massachusetts remains grim. The controlled shutdown of MedMen Enterprises continues under California-based receiver Richard Ormond. In a recent update, Ormond indicated that sales of most former MedMen dispensaries are in progress, with some locations being abandoned and four in Southern California still operational.
Michelle Deleissegues Details GEM-Pack's Foodservice Program, Major Growth, and Expanded Value
WATSONVILLE, CA - Primed for growth and striving for constant evolution, GEM-Pack Berries has been making strides across the fresh produce industry in invaluable ways. As we approach the 2024 International Fresh Produce Association’s Foodservice Conference, Michelle Deleissegues, Senior Vice President of Marketing, GEM-Pack, joined me to discuss what is on the horizon for the company and what advantages are impacting its customers today.
Navy Exonerates 258 Black Sailors Unjustly Punished After 1944 California Explosion
The U.S. Navy exonerated on Wednesday 258 Black sailors who were unjustly court-martialed and punished for refusing to follow orders after an explosion that killed more than 300 people in a California port 80 years ago. On the night of July 17, 1944, an explosion with nearly the force of...
Gem-Pack Berries Debuts New Website; Michelle Deleissegues Talks Enhanced User Experience and Performance
WATSONVILLE, CA - In the era of connectivity, a digital pathway to your company is a must. Putting its best foot forward in this regard, Gem-Pack Berries recently announced the launch of its newest website. With a dazzling new design and enhanced functionality, it is now easier than ever for users to connect with Gem-Pack’s products.
Weeklys staff recognized at California Journalism Awards gala
Several Los Gatan contributors were honored by the California News Publishers Association at the 2023 California Journalism Awards gala in Los Angeles Saturday for work in sister publications. Todd Guild, a Weeklys editor, won first place in the Coverage of Youth and Education category for an article about court-ordered therapy...
Liccardo outspends Low as 16th District war chests grow
Sam Liccardo is raising more money, spending more money and has more money in the bank than Evan Low in California’s 16th Congressional District contest, according to financial reports both candidates filed Monday with the Federal Election Commission. These new numbers continue the trends set in the first quarter,...
California cops apparently want Cybertrucks now
LOS ANGELES - Tesla patrol vehicles aren't something new in California. Police departments across the Golden State already use or are testing Tesla patrol cars. The Anaheim Police Department, for example, debuted Model Y patrol vehicles in April. "The Tesla Model Y was selected for its advanced features, including rapid...
Galvani Bioelectronics Announces Clinical Progression of Its Therapy Platform and Addition of New Chief Medical Officer
SAN FRANCISCO--(BUSINESS WIRE)--Jul 17, 2024-- Galvani Bioelectronics, a clinical-stage therapeutics company formed through a strategic partnership between GSK and Verily Life Sciences to develop targeted neuromodulation therapies, today announced it is recruiting the randomized, controlled stage of a clinical feasibility study for patients with Rheumatoid Arthritis (RA). This progression has been approved by the US Food and Drug Administration (FDA) following review of safety and initial effectiveness from a first group of patients. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240717729913/en/ Picture of Dr. Raolat Abdulai (Photo: Business Wire)
Welcome to NewsBreak, an open platform where diverse perspectives converge. Most of our content comes from established publications and journalists, as well as from our extensive network of tens of thousands of creators who contribute to our platform. We empower individuals to share insightful viewpoints through short posts and comments. It’s essential to note our commitment to transparency: our Terms of Use acknowledge that our services may not always be error-free, and our Community Standards emphasize our discretion in enforcing policies. We strive to foster a dynamic environment for free expression and robust discourse through safety guardrails of human and AI moderation. Join us in shaping the news narrative together.